These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. HIV Infection, hepatitis C infection, and HAART: hard clinical choices. Kottilil S; Polis MA; Kovacs JA JAMA; 2004 Jul; 292(2):243-50. PubMed ID: 15249574 [TBL] [Abstract][Full Text] [Related]
24. Drug combination treats HIV and HCV. AIDS Patient Care STDS; 2004 Apr; 18(4):251. PubMed ID: 15142356 [No Abstract] [Full Text] [Related]
28. Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus. Aguilar Marucco D; Veronese L; de Requena DG; Bonora S; Calcagno A; Cavecchia I; Sinicco A; De Rosa FG; Cariti G; Di Perri G J Antimicrob Chemother; 2007 Mar; 59(3):565-8. PubMed ID: 17213263 [TBL] [Abstract][Full Text] [Related]
29. Ribavirin in combination therapy for HCV chronic infection in HIV patients: how to win the war after winning the first battle? Souvignet C; Maynard M; Gagnieu MC; Trepo C J Hepatol; 2007 Jul; 47(1):1-3. PubMed ID: 17509722 [No Abstract] [Full Text] [Related]
30. Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study. Tural C; Solà R; Rubio R; Santín M; Planas R; Quereda C; Berenguer J; Montes-Ramírez M; Clotet B; J Viral Hepat; 2007 Oct; 14(10):704-13. PubMed ID: 17875005 [TBL] [Abstract][Full Text] [Related]
31. [Chronic hepatitis C viral infection with persistent normal serum alanine aminotransferases]. Huang CX; Bai XF Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):70-1. PubMed ID: 15670508 [No Abstract] [Full Text] [Related]
32. [Chronic hepatitis C. First treatment]. Colombato L; Descalzi V; Gadano A Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S37-9. PubMed ID: 20214297 [No Abstract] [Full Text] [Related]
37. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy. Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579 [TBL] [Abstract][Full Text] [Related]
38. Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin. Núñez M; Ocampo A; Aguirrebengoa K; Cervantes M; Pascual A; Echeverria S; Asensi V; Barreiro P; Garcia-Samaniego J; Soriano V; J Viral Hepat; 2008 May; 15(5):363-9. PubMed ID: 18179454 [TBL] [Abstract][Full Text] [Related]